[LSK Global PS] CRº»ºÎ CRA °æ·Â
ä¿ë |
||
LSK¿Í ÇÔ²² ÇÏ½Ç ¿ª·® ÀÖ´Â ¿©·¯ºÐµéÀÇ ¸¹Àº Áö¿ø ¹Ù¶ø´Ï´Ù. |
||
´ã´ç¾÷¹« ¹× Áö¿øÀÚ°Ý |
||
CRº»ºÎ CRÆÀ |
Clinical Research Associate
(CRA) °æ·Â |
|
[´ã´ç¾÷¹«] n CRAs primary responsibility is to
build relationships with Principal Investigators, study co-ordinators,
pharmacists, and all relevant site trial personnel to ensure the efficient,
expedited, and smooth management of project. n Work in a timely manner in accordance
with the agreed budget, under the supervision of the project manager(PM) n Communicate with the PM, other CRAs,
Sponsor and site staff as appropriate n Conduct initiation, interim
monitoring, and close-out visits n Undertake monitoring visit within the
correct timeline and ensure with report that all activities such as source
data verification and drug accountability are completed [Çʼö»çÇ×] n ÀÓ»ó½ÃÇè 1~4»ó ¸ð´ÏÅ͸µ
°æ·Â(Çã°¡ÀÓ»ó °æÇè Çʼö), 1³â ÀÌ»ó n Àü°ø: °£È£ÇÐ, ¾àÇÐ, ¼öÀÇÇÐ, ÀÚ¿¬°úÇÐ, »ý¸í°úÇÐ, º¸°Ç°è¿ °ü·Ã Àü°øÀÚ n Çã°¡ ÀÓ»ó½ÃÇè ¿¬±¸ °æÇè,
Oncology ÀÓ»ó½ÃÇè °æÇèÀÚ ¿ì´ë [¿ì´ë»çÇ×] n IIT ¿¬±¸ °æÇè, Oncology ÀÓ»ó½ÃÇè °æÇèÀÚ ¿ì´ë n ºü¸¥ÀÔ»ç °¡´ÉÀÚ |
||
1)
Á¢¼ö¹æ¹ý ¹× ÀüÇüÀýÂ÷ |
||
¨ç
À̸ÞÀÏ |
******@*******.*** |
¾ç½Ä¸í(ÆÀ_Á÷¹«_À̸§): CRº»ºÎ_CRA_OOO |
¨è
±â°£ |
~ ä¿ë½Ã ¸¶°¨ |
|
¨é
ÀüÇüÀýÂ÷ |
¼·ùÀüÇü -> (¿Â¶óÀÎ)Àμº°Ë»ç -> ¸éÁ¢ÀüÇü
-> ÃÖÁ¾ÇÕ°Ý |
|
2)
Á¦Ãâ¼·ù |
||
- Àå¾ÖÀÎ ¿ì´ë (*ÃÖÁ¾ÇÕ°Ý
½Ã Àå¾ÖÀεî·ÏÁõ Á¦Ãâ °¡´ÉÀÚ) -
±¹°¡º¸ÈÆ´ë»óÀÚ ¿ì´ë
(*Áö¿ø ½Ã "Ãë¾÷Áö¿ø´ë»óÀÚ Áõ¸í¼" ¼·ù ÇÔ²² Á¦Ãâ) |
||
¨ç
´ç»ç ¾ç½ÄÀÇ ÀÔ»çÁö¿ø¼ Á¦Ãâ (÷ºÎÆÄÀÏ È®ÀÎ) |
||
¨è
À̷¼ »çÁø ÷ºÎ ¹× Áö¿øºÎ¼ ±âÀç Çʼö, °æ·ÂÁö¿øÀÚ´Â
°æ·Â±â¼ú¼ ³»¿ë Çʼö |
||
¨é
Èñ¸Á¿¬ºÀ ±âÀç¹Ù¶÷ |
||
3)
±Ù¹«È¯°æ |
||
¨ç
±Ù¹«½Ã°£ |
¼±ÅÃÀû ±Ù·Î½Ã°£Á¦(¿ÀÀü 8½Ã~10½Ã) |
|
¨è
ÈÞ°¡ |
¿¬Â÷, °æÁ¶»çÈÞ°¡, Ãâ»êÀüÈÄÈÞ°¡, ¹è¿ìÀÚÃâ»êÈÞ°¡, RefreshÈÞ°¡(¿¬Â÷º°µµ) |
|
¨é
º¸Çè |
4´ëº¸Çè, »óÇØº¸Çè |
|
¨ê
º¹¸®ÈÄ»ý |
- ³»/¿ÜºÎ ±³À°ºñ Áö¿ø - º¹ÁöÆ÷ÀÎÆ® Áö±Þ - °¢Á¾ °æÁ¶±Ý(°áÈ¥/ȸ°©/Á¶ÀÇ µî) ¹× Èȯ, »óÁ¶¿ëǰ
¹ß¼Û - ÅðÁ÷¿¬±Ý(DCÇü) - ³»ºÎÃßõ Àμ¾Æ¼ºêÁ¦ - Àå±â±Ù¼ÓÆ÷»ó(Æ÷»ó±Ý ¹× Æ÷»óÈÞ°¡) - Åë½Åºñ ¹× ¾ß°£Åýúñ Áö±Þ(ÇØ´çÀÚ) - ¸íÀý, ⸳±â³äÀÏ, ±Ù·ÎÀÚÀÇ ³¯ ¼±¹°(¹éÈÁ¡ »óǰ±Ç) - ¹ýÀÎ ¸®Á¶Æ®(ȸ¿ø°¡ ÀÌ¿ë) - ÀÚ³àÃàÇϱÝ(Ãâ»êÃàÇϱÝ/ÀÔÇÐÃàÇϱÝ) - À°¾Æº¸Á¶±Ý(1~7¼¼ ¿µÀ¯¾Æ(¸Å¿ù)) ¹× ÀÚ³àÇÐÀÚ±Ý(Çѵµ
³» ½ÇºñÁ¤»ê)) - Á¾Çհǰ°ËÁø Áö¿ø(2³âÁÖ±â/Áö¿ªº° ¼±Á¤¾÷ü) - ±âŸÈÞ°¡(ÀÓ»êºÎ°ËÁø/¿µÀ¯¾Æ°ËÁø/°Ç°°ËÁø/Á¹¾÷½Ä µî) - À¯¿¬±Ù¹«Á¦(¼±ÅÃÀû ±Ù·Î½Ã°£Á¦) - Refresh ÈÞ°¡(¿¬Â÷ º°µµ) |
|
4)
´ã´çÀÚ Á¤º¸ |
||
-
°æ¿µÁö¿øÆÀ |
À̸ÞÀÏ ¹®ÀÇ : ******@*******.*** |
|
5)
±Ù¹«Ã³ |
||
¨ç
º»»ç |
¼¿ï½Ã Áß±¸ Åð°è·Î 97 °í·Á´ë¿¬°¢Å¸¿ö 14Ãþ |
|
¨è
À§Ä¡ |
[4È£¼±] ¸íµ¿¿ª 5¹ø
Ãⱸ(200m) µµº¸ 3ºÐ, [2È£¼±] À»Áö·ÎÀÔ±¸¿ª 6¹øÃⱸ(600m) µµº¸ 8ºÐ |
¡Ø ä¿ëÀýÂ÷ÀÇ °øÁ¤È¿¡ °üÇÑ ¹ý·ü¿¡ ÀǰÅÇÏ¿© ä¿ë ¿©ºÎ
È®Á¤ ÈÄ ±¸Á÷ÀÚ´Â 14ÀÏ À̳» ä¿ë¼·ù ¹Ýȯ û±¸°¡ °¡´ÉÇÕ´Ï´Ù. (È®Á¤µÈ
ä¿ë ´ë»óÀÚ´Â Á¦¿ÜÇÕ´Ï´Ù.)
´Ù¸¸, ȨÆäÀÌÁö ¶Ç´Â ÀüÀÚ¿ìÆíÀ¸·Î Á¦ÃâµÈ °æ¿ì¿¡´Â ÇØ´çµÇÁö ¾ÊÀ¸¸ç ä¿ë ¼·ù ¹ÝȯÀ» Èñ¸ÁÇÏ´Â ±¸Á÷ÀÚ´Â À̸ÞÀÏ(******@*******.***)À» ÅëÇØ ½ÅûÇϽøé
¿ìÆíÀ» ÅëÇØ ¹ÝȯÇÏ¿© µå¸³´Ï´Ù.